Arctic Bioscience AS EV/EBIT

Que fait Arctic Bioscience AS ? Arctic Bioscience AS develops marine ingredients from herring roe for autoimmune disorder therapies, focusing on HRO350 for psoriasis treatment. The company markets B2B products like herring caviar oil and protein through subsidiaries such as Arctic Nutrition AS and Romega AS, which produces omega-3 supplements in capsule form. Its product Romega targets consumers seeking dietary supplements, while B2B segments buy herring roe-derived ingredients for further processing. The firm's subsidiaries handle distinct segments: Arctic Nutrition AS focuses on nutritional products, Romega AS on dietary supplements, and Arctic Biopharma AS on drug development. Arctic Bioscience AS generates revenue through B2B sales of herring caviar oil and protein, alongside consumer sales of Romega omega-3 capsules. HRO350 remains in development but is positioned for future therapeutic sales. Subsidiaries like Romega AS directly serve end-users with dietary supplements, while Arctic Nutrition AS and Arctic Biopharma AS support B2B and clinical development needs. The company’s strategy aligns with its purpose of providing marine membrane lipid-based therapies for autoimmune conditions. The firm’s revenue streams include Romega’s omega-3 dietary supplements sold to consumers and herring caviar oil/protein sold to businesses. Arctic Nutrition AS and Romega AS operate within the B2B and consumer markets, respectively, while Arctic Biopharma AS develops HRO350 for psoriasis treatment. All products derive from herring roe extraction, with no additional brands or products mentioned in the business description. Arctic Bioscience AS est l'une des entreprises les plus populaires sur Eulerpool.